Farid A. Badria

Mansoura University

Professor Farid Badria, Ph.D. in Pharmacognosy (Microbial Transformation) from the Uni-versity of Mississippi, USA, with a B.Sc. in Pharmaceutical Sciences, and 2 Masters of Sci-ence in Pharmacognosy and Cell Biology from Mansoura University and the University of Minnesota. TWAS-Prize for "Public Understanding and Popularization of Science" (2013), World Intel-lectual Property Organization Gold Medal, 2011[the best Inventor in Egypt]; State Recogni-tion Outstanding Award in Medicine (Egyptian Academy of Science) 2001; Outstanding Arab Scholar, Kuwait (2000); Khawrazmi International Award, Iran (2000), are just to men-tion some of the awards he received. He’s also been a scholar of: the Arab Development Fund, Kuwait (2000); ICRO-UNESCO International, Chile (1999); UNESCO Biotechnology Fellowship, France (1994); Honorary Fellowship, University of Mississippi, USA (1987-90). Prof. Badria has submitted 44 patents to the Egyptian Academy of Sciences, of which 16 had been granted final certificates with intellectual protection for 20 years. With over 200 publications, 4 books, editor of 5 books, He continues to lead research projects on: developing new therapy for liver disorders, arthritis, skin disorders, and biomarkers for cancer. Prof. Farid Badria is actively involved in international collaboration as visiting Professor, Institut fur Physiologische Chemie, Abteilung Angewandte Moleku-larbiologie, Mainz, Germany; School of Medicine, University of Roma, Italy, School of Pharmacy, University of Minnesota, Italy. Prof. Badria participated as invited speaker/and or organizer in international conferences in well known research institutes in Switzerland, Malysia, Indone-sia Italy, Cuba, Tunisia, Iran, Germany, Senegal, India, Chile, Romania, USA, Canada, Mexico, and other countries.

4books edited

1chapters authored

Latest work with IntechOpen by Farid A. Badria

The intent of this book is to provide an overview of current conceptualizations of Pharmacotherapy. The book focuses on three major areas; diagnosis, treatment, and prevention for a wide array of diseases; Cognitive and Psychological disorders (Schizophrenia and Nicotine addiction), Inflammatory disorders (New Chemical anti-inflammatory and Immunotherapy), updated antihypertensive therapy and healing of ulcers with venous origin. A separate chapter is dedicated to the rationality of drug use in earthquake injuries. The last chapter deals with Imaging of potential therapeutic or diagnostic agents in animal models in the early stage of research. We hope this book is useful to a wide range of people, from students first learning about Pharmacotherapy, to advanced clinicians and researchers.

Go to the book